Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice

Maria Grazia Sacco, Laura Gribaldo, Ottavia Barbieri, Gino Turchi, Ileana Zucchi, Angelo Collotta, Luca Bagnasco, Domenico Barone, Cristina Montagna, Anna Villa, Erminio Marafante, Paolo Vezzoni

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

A new murine cell line, named MG1361, was established from mammary adenocarcinomas arising in a MMTV-neu transgenic mouse lineage where breast tumors develop in 100% of females, due to the overexpression of the activated rat neu oncogene in the mammary gland. The MG1361 cell line shows an epithelial-like morphology, has a poor plating efficiency, low clonogenic capacity, and a doubling time of 23.8 hours. Karyotype and flow cytometry analysis revealed a hypotetraploid number of chromosomes, whereas cell cycle analysis showed 31.2% of cells to be in the G1 phase, 21.4% in S and 47.4% in G2 + M. This cell line maintains a high level of neu expression in vitro. The MG1361 cell line was tumorigenic when inoculated in immunodeficient (nude) mice and the derived tumors showed the same histological features as the primary tumors from which they were isolated. MG1361 cells were positive for specific ER and PgR binding which was competed by tamoxifen, making this cell line useful for the evaluation of endocrine therapy. Moreover, they were sensitive to etoposide treatment, suggesting that they could be a model for the study of chemotherapy-induced apoptosis. As the tumors arising in MMTV-neu transgenic mice have many features in common with human mammary adenocarcinomas, this cell line can be utilized to perform basic studies on the role of the neu oncogene in the maintenance of the transformed phenotype, and to test novel protocols of therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)171-180
Number of pages10
JournalBreast Cancer Research and Treatment
Volume47
Issue number2
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Transgenic Mice
Adenocarcinoma
Breast
Cell Line
Oncogenes
Neoplasms
G1 Phase
Etoposide
Tamoxifen
Human Mammary Glands
Karyotype
Nude Mice
Cell Cycle
Flow Cytometry
Therapeutics
Chromosomes
Maintenance
Apoptosis
Breast Neoplasms
Phenotype

Keywords

  • Apoptosis
  • Breast cancer
  • Hormone responsiveness
  • Mammary adenocarcinoma cell line
  • MG 1361
  • MMTV-neu transgenic mice

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice. / Sacco, Maria Grazia; Gribaldo, Laura; Barbieri, Ottavia; Turchi, Gino; Zucchi, Ileana; Collotta, Angelo; Bagnasco, Luca; Barone, Domenico; Montagna, Cristina; Villa, Anna; Marafante, Erminio; Vezzoni, Paolo.

In: Breast Cancer Research and Treatment, Vol. 47, No. 2, 1998, p. 171-180.

Research output: Contribution to journalArticle

Sacco, MG, Gribaldo, L, Barbieri, O, Turchi, G, Zucchi, I, Collotta, A, Bagnasco, L, Barone, D, Montagna, C, Villa, A, Marafante, E & Vezzoni, P 1998, 'Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice', Breast Cancer Research and Treatment, vol. 47, no. 2, pp. 171-180. https://doi.org/10.1023/A:1005988715285
Sacco, Maria Grazia ; Gribaldo, Laura ; Barbieri, Ottavia ; Turchi, Gino ; Zucchi, Ileana ; Collotta, Angelo ; Bagnasco, Luca ; Barone, Domenico ; Montagna, Cristina ; Villa, Anna ; Marafante, Erminio ; Vezzoni, Paolo. / Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice. In: Breast Cancer Research and Treatment. 1998 ; Vol. 47, No. 2. pp. 171-180.
@article{895439e96f934ce18db6b25b91ed9867,
title = "Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice",
abstract = "A new murine cell line, named MG1361, was established from mammary adenocarcinomas arising in a MMTV-neu transgenic mouse lineage where breast tumors develop in 100{\%} of females, due to the overexpression of the activated rat neu oncogene in the mammary gland. The MG1361 cell line shows an epithelial-like morphology, has a poor plating efficiency, low clonogenic capacity, and a doubling time of 23.8 hours. Karyotype and flow cytometry analysis revealed a hypotetraploid number of chromosomes, whereas cell cycle analysis showed 31.2{\%} of cells to be in the G1 phase, 21.4{\%} in S and 47.4{\%} in G2 + M. This cell line maintains a high level of neu expression in vitro. The MG1361 cell line was tumorigenic when inoculated in immunodeficient (nude) mice and the derived tumors showed the same histological features as the primary tumors from which they were isolated. MG1361 cells were positive for specific ER and PgR binding which was competed by tamoxifen, making this cell line useful for the evaluation of endocrine therapy. Moreover, they were sensitive to etoposide treatment, suggesting that they could be a model for the study of chemotherapy-induced apoptosis. As the tumors arising in MMTV-neu transgenic mice have many features in common with human mammary adenocarcinomas, this cell line can be utilized to perform basic studies on the role of the neu oncogene in the maintenance of the transformed phenotype, and to test novel protocols of therapeutic strategies.",
keywords = "Apoptosis, Breast cancer, Hormone responsiveness, Mammary adenocarcinoma cell line, MG 1361, MMTV-neu transgenic mice",
author = "Sacco, {Maria Grazia} and Laura Gribaldo and Ottavia Barbieri and Gino Turchi and Ileana Zucchi and Angelo Collotta and Luca Bagnasco and Domenico Barone and Cristina Montagna and Anna Villa and Erminio Marafante and Paolo Vezzoni",
year = "1998",
doi = "10.1023/A:1005988715285",
language = "English (US)",
volume = "47",
pages = "171--180",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice

AU - Sacco, Maria Grazia

AU - Gribaldo, Laura

AU - Barbieri, Ottavia

AU - Turchi, Gino

AU - Zucchi, Ileana

AU - Collotta, Angelo

AU - Bagnasco, Luca

AU - Barone, Domenico

AU - Montagna, Cristina

AU - Villa, Anna

AU - Marafante, Erminio

AU - Vezzoni, Paolo

PY - 1998

Y1 - 1998

N2 - A new murine cell line, named MG1361, was established from mammary adenocarcinomas arising in a MMTV-neu transgenic mouse lineage where breast tumors develop in 100% of females, due to the overexpression of the activated rat neu oncogene in the mammary gland. The MG1361 cell line shows an epithelial-like morphology, has a poor plating efficiency, low clonogenic capacity, and a doubling time of 23.8 hours. Karyotype and flow cytometry analysis revealed a hypotetraploid number of chromosomes, whereas cell cycle analysis showed 31.2% of cells to be in the G1 phase, 21.4% in S and 47.4% in G2 + M. This cell line maintains a high level of neu expression in vitro. The MG1361 cell line was tumorigenic when inoculated in immunodeficient (nude) mice and the derived tumors showed the same histological features as the primary tumors from which they were isolated. MG1361 cells were positive for specific ER and PgR binding which was competed by tamoxifen, making this cell line useful for the evaluation of endocrine therapy. Moreover, they were sensitive to etoposide treatment, suggesting that they could be a model for the study of chemotherapy-induced apoptosis. As the tumors arising in MMTV-neu transgenic mice have many features in common with human mammary adenocarcinomas, this cell line can be utilized to perform basic studies on the role of the neu oncogene in the maintenance of the transformed phenotype, and to test novel protocols of therapeutic strategies.

AB - A new murine cell line, named MG1361, was established from mammary adenocarcinomas arising in a MMTV-neu transgenic mouse lineage where breast tumors develop in 100% of females, due to the overexpression of the activated rat neu oncogene in the mammary gland. The MG1361 cell line shows an epithelial-like morphology, has a poor plating efficiency, low clonogenic capacity, and a doubling time of 23.8 hours. Karyotype and flow cytometry analysis revealed a hypotetraploid number of chromosomes, whereas cell cycle analysis showed 31.2% of cells to be in the G1 phase, 21.4% in S and 47.4% in G2 + M. This cell line maintains a high level of neu expression in vitro. The MG1361 cell line was tumorigenic when inoculated in immunodeficient (nude) mice and the derived tumors showed the same histological features as the primary tumors from which they were isolated. MG1361 cells were positive for specific ER and PgR binding which was competed by tamoxifen, making this cell line useful for the evaluation of endocrine therapy. Moreover, they were sensitive to etoposide treatment, suggesting that they could be a model for the study of chemotherapy-induced apoptosis. As the tumors arising in MMTV-neu transgenic mice have many features in common with human mammary adenocarcinomas, this cell line can be utilized to perform basic studies on the role of the neu oncogene in the maintenance of the transformed phenotype, and to test novel protocols of therapeutic strategies.

KW - Apoptosis

KW - Breast cancer

KW - Hormone responsiveness

KW - Mammary adenocarcinoma cell line

KW - MG 1361

KW - MMTV-neu transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=14444275536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14444275536&partnerID=8YFLogxK

U2 - 10.1023/A:1005988715285

DO - 10.1023/A:1005988715285

M3 - Article

VL - 47

SP - 171

EP - 180

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -